Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography
- PMID: 29159268
- PMCID: PMC5675709
- DOI: 10.1016/j.dadm.2017.09.001
Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography
Abstract
Introduction: We investigated the association between olfactory identification and Alzheimer's disease biomarkers, including amyloid, tau, and neurodegeneration.
Methods: Thirty-four older adults, including 19 cognitively normal (CN), 10 subjective cognitive decline (SCD), and 5 mild cognitive impairment, underwent amyloid positron emission tomography, magnetic resonance imaging, and the University of Pennsylvania Smell Identification Test (UPSIT). Twenty-six also underwent tau positron emission tomography. Associations between the UPSIT and regionally sampled amyloid, tau, and temporal atrophy were evaluated. Voxel-wise regression models were also utilized. Analyses were conducted with the full sample and only CN/SCD.
Results: Lower UPSIT scores were associated with increased temporal and parietal tau burden in regional and voxel-wise analyses in the full sample and in CN and SCD only. Temporal lobe atrophy was associated with lower UPSIT score. Amyloid was not associated with the UPSIT.
Discussion: Impairment on the UPSIT may be a good marker for tau and neurodegeneration in preclinical or prodromal Alzheimer's disease.
Keywords: Alzheimer's disease; Neurodegeneration; Olfaction; Tau; [18F]Flortaucipir (AV-1451).
Figures




Similar articles
-
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334. Brain. 2017. PMID: 28077397 Free PMC article.
-
Visual contrast sensitivity is associated with the presence of cerebral amyloid and tau deposition.Brain Commun. 2020;2(1):fcaa019. doi: 10.1093/braincomms/fcaa019. Epub 2020 Feb 26. Brain Commun. 2020. PMID: 32309804 Free PMC article.
-
Odor Identification Ability Predicts PET Amyloid Status and Memory Decline in Older Adults.J Alzheimers Dis. 2018;62(4):1759-1766. doi: 10.3233/JAD-170960. J Alzheimers Dis. 2018. PMID: 29614678 Free PMC article.
-
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.Brain. 2019 Jun 1;142(6):1723-1735. doi: 10.1093/brain/awz090. Brain. 2019. PMID: 31009046 Free PMC article.
-
Amyloid and Tau Biomarkers in Subjective Cognitive Impairment.J Alzheimers Dis. 2015;47(1):1-8. doi: 10.3233/JAD-150180. J Alzheimers Dis. 2015. PMID: 26402749 Review.
Cited by
-
Ultrarapid Inflammation of the Olfactory Bulb After Spinal Cord Injury: Protective Effects of the Granulocyte Colony-Stimulating Factor on Early Neurodegeneration in the Brain.Front Aging Neurosci. 2021 Jun 25;13:701702. doi: 10.3389/fnagi.2021.701702. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34248610 Free PMC article.
-
An experimental model of Braak's pretangle proposal for the origin of Alzheimer's disease: the role of locus coeruleus in early symptom development.Alzheimers Res Ther. 2019 Jul 3;11(1):59. doi: 10.1186/s13195-019-0511-2. Alzheimers Res Ther. 2019. PMID: 31266535 Free PMC article.
-
Blood NCAPH2 Methylation Is Associated With Hippocampal Volume in Subjective Cognitive Decline With Apolipoprotein E ε4 Non-carriers.Front Aging Neurosci. 2021 Feb 2;13:632382. doi: 10.3389/fnagi.2021.632382. eCollection 2021. Front Aging Neurosci. 2021. PMID: 33603659 Free PMC article.
-
Association between BrainAGE and Alzheimer's disease biomarkers.Alzheimers Dement (Amst). 2025 Feb 27;17(1):e70094. doi: 10.1002/dad2.70094. eCollection 2025 Jan-Mar. Alzheimers Dement (Amst). 2025. PMID: 40018325 Free PMC article.
-
Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition.Alzheimers Dement (Amst). 2019 Jul 26;11:510-519. doi: 10.1016/j.dadm.2019.05.007. eCollection 2019 Dec. Alzheimers Dement (Amst). 2019. PMID: 31384662 Free PMC article.
References
-
- McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Jr., Kawas C.H. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:263–269. - PMC - PubMed
-
- Albert M.S., DeKosky S.T., Dickson D., Dubois B., Feldman H.H., Fox N.C. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:270–279. - PMC - PubMed
-
- Djordjevic J., Jones-Gotman M., De Sousa K., Chertkow H. Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging. 2008;29:693–706. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources